Blog: The Myriad gene patent case: its potential impact on the...

Aug 1, 2012 | Posted by: roboblogger | Full story: Mass High Tech

Recently, a federal appeals court heard oral arguments in a patent case, the ruling in which could significantly impact Massachusetts-based academic research organizations, biotechnology companies, and pharmaceutical companies.

Comments
1 - 2 of 2 Comments Last updated Aug 6, 2012
Julius

United States

|
Report Abuse
|
Judge it!
|
#1
Aug 6, 2012
 
Does Mitt Romney/Bain Capital have financial interests in Utah diagnostic company Myriad Genetics?
dexter

United States

|
Report Abuse
|
Judge it!
|
#2
Aug 6, 2012
 
Seems as if someone should look into this. Do you have information on this matter? You seem to be suggesting such given your question.

Tell me when this thread is updated: (Registration is not required)

Add to my Tracker Send me an email

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Biotech Discussions

Title Updated Last By Comments
Lawsuits filed over Lipitor side effects (Jun '06) 4 hr kylie 848
Merck's shingles vaccine, Zostavax, recommended... (Jun '08) Aug 18 Susanna 75
40 percent of Americans will develop diabetes Aug 13 humanSpirit 1
Robin Williams' suicide: How to get help for su... Aug 12 Big mike 2
Genital herpes common, but percentage is declining (Jul '08) Aug 12 Jhon Cordova Orbe... 46
US labs ready to work on Ebola drugs if asked Aug 10 Hurry up 1
Experts: US is ready for Ebola Aug 6 Test it 10

Search the Biotech Forum:
•••